| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Cash and cash equivalents | 1,319 | 786 | ||
| Accounts receivable | 3 | 5 | ||
| Inventory | 22 | 27 | ||
| Prepaid research and development | 53 | 53 | ||
| Prepaid expenses and other current assets | 230 | 246 | ||
| Total current assets | 1,627 | 1,117 | ||
| Property, plant and equipment, net | 7 | 8 | ||
| Right-of-use assets, net | 221 | 245 | ||
| Long-term prepaid contracts | 691 | 767 | ||
| Total assets | 2,546 | 2,137 | ||
| Accounts payable | 313 | 352 | ||
| Accrued and other current liabilities | 327 | 563 | ||
| Deferred revenue | 128 | 149 | ||
| Insurance premium financing payable | 0 | 63 | ||
| Operating lease liability | 108 | 104 | ||
| Total current liabilities | 876 | 1,231 | ||
| Operating lease liability, net of current portion | 116 | 145 | ||
| Total liabilities | 992 | 1,376 | ||
| Common stock, par value 0.01 per share, 60,000,000 shares authorized 17,168,979 and 15,918,979 shares issued and outstanding at september 30, 2025 and december 31, 2024, respectively | 172 | 159 | ||
| Additional paid-in capital | 106,261 | 103,779 | ||
| Accumulated deficit | -104,870 | -103,170 | ||
| Accumulated other comprehensive loss | -9 | -7 | ||
| Total stockholders equity | 1,554 | 761 | ||
| Total liabilities and stockholders equity | 2,546 | 2,137 | ||
Harvard Apparatus Regenerative Technology, Inc. (HRGN)
Harvard Apparatus Regenerative Technology, Inc. (HRGN)